Vivos Therapeutics Inc (NASDAQ: VVOS)’s stock price has dropped by -6.90 in relation to previous closing price of 2.90. Nevertheless, the company has seen a gain of 2.27% in its stock price over the last five trading days. proactiveinvestors.com reported 2024-10-08 that Vivos Therapeutics (NASDAQ:VVOS) announced that the American Medical Association (AMA) has granted new CPT codes for the company’s Vivos CARE oral medical devices. Effective January 1, 2025, these codes will streamline insurance coverage and reimbursement for Vivos’ devices, designed to treat obstructive sleep apnea (OSA) in both adults and children.
Is It Worth Investing in Vivos Therapeutics Inc (NASDAQ: VVOS) Right Now?
VVOS has 36-month beta value of 7.69. Analysts have mixed views on the stock, with 2 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for VVOS is 4.28M, and currently, short sellers hold a 1.63% ratio of that float. The average trading volume of VVOS on October 31, 2024 was 1.33M shares.
VVOS’s Market Performance
VVOS stock saw an increase of 2.27% in the past week, with a monthly gain of 7.14% and a quarterly increase of 24.42%. The volatility ratio for the week is 7.36%, and the volatility levels for the last 30 days are 7.42% for Vivos Therapeutics Inc (VVOS). The simple moving average for the past 20 days is 5.20% for VVOS’s stock, with a -16.91% simple moving average for the past 200 days.
VVOS Trading at -1.79% from the 50-Day Moving Average
After a stumble in the market that brought VVOS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -94.47% of loss for the given period.
Volatility was left at 7.42%, however, over the last 30 days, the volatility rate increased by 7.36%, as shares surge +11.11% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -11.48% lower at present.
During the last 5 trading sessions, VVOS rose by +2.27%, which changed the moving average for the period of 200-days by -62.29% in comparison to the 20-day moving average, which settled at $2.57. In addition, Vivos Therapeutics Inc saw -78.30% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for VVOS
Current profitability levels for the company are sitting at:
- -0.95 for the present operating margin
- 0.58 for the gross margin
The net margin for Vivos Therapeutics Inc stands at -0.86. The total capital return value is set at -1.45. Equity return is now at value -284.99, with -81.41 for asset returns.
Based on Vivos Therapeutics Inc (VVOS), the company’s capital structure generated 0.22 points at debt to capital in total, while cash flow to debt ratio is standing at -6.3. The debt to equity ratio resting at 0.28. The interest coverage ratio of the stock is -4.04.
Currently, EBITDA for the company is -16.68 million with net debt to EBITDA at 0.4. When we switch over and look at the enterprise to sales, we see a ratio of 0.55. The receivables turnover for the company is 35.5for trailing twelve months and the total asset turnover is 0.89. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.18.
Conclusion
To put it simply, Vivos Therapeutics Inc (VVOS) has had a mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
